GYRE
Gyre Therapeutics
$7.09
+$0.56 (+8.58%)Oct 28, 2026
Key metrics
The numbers that frame GYRE today
- Market cap
- $790.60M
- Gross margin
- 94.3%
- EV / Sales
- 6.3
- ROIC
- -12.9%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $5.44
- 52wk High
- $9.14
Growth
Revenue and earnings trend for GYRE
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about GYRE
Is Gyre Therapeutics a good buy?
Hold. Gyre Therapeutics has weak quality and mixed momentum. The setup is mixed. Growth looks poor. That could put pressure on the long-term business case. We think Gyre Therapeutics is selling at a high price.
What is the market capitalization of GYRE?
Gyre Therapeutics's market capitalization is $790.60M.
What is the 52-week high for GYRE stock?
The 52-week high for Gyre Therapeutics is $9.14. The current close of $7.09 is 22.4% below that high.
What is the 52-week low for GYRE stock?
The 52-week low for Gyre Therapeutics is $5.44. The current close of $7.09 is 30.3% above that low.
Does GYRE stock pay dividends?
Gyre Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for GYRE?
Gyre Therapeutics's Debt / Equity ratio is 0.03.